Ranbaxy Laboratories, a drug firm declared on Thursday that the consolidated net loss increased to Rs.2, 982.7 crore in the fourth quarter which ended on December 31st, 2011. While, over the same period previous year the company posted a net loss of Rs 97.4 crore. On the brighter side, net sales of the company, rose […]
Continue Reading...
